393 related articles for article (PubMed ID: 30550996)
1. Nanostructured lipid carriers: A potential use for skin drug delivery systems.
Czajkowska-Kośnik A; Szekalska M; Winnicka K
Pharmacol Rep; 2019 Feb; 71(1):156-166. PubMed ID: 30550996
[TBL] [Abstract][Full Text] [Related]
2. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
3. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
Müller RH; Radtke M; Wissing SA
Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S131-55. PubMed ID: 12460720
[TBL] [Abstract][Full Text] [Related]
6. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Jain S; Patel N; Shah MK; Khatri P; Vora N
J Pharm Sci; 2017 Feb; 106(2):423-445. PubMed ID: 27865609
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
9. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
10. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
Dobreva M; Stefanov S; Andonova V
Curr Pharm Des; 2020; 26(36):4524-4535. PubMed ID: 32410552
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles for dermal drug delivery.
Kakadia PG; Conway BR
Curr Pharm Des; 2015; 21(20):2823-9. PubMed ID: 25925115
[TBL] [Abstract][Full Text] [Related]
12. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
13. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
14. Vesicles: a recently developed novel carrier for enhanced topical drug delivery.
Akhtar N
Curr Drug Deliv; 2014; 11(1):87-97. PubMed ID: 24533724
[TBL] [Abstract][Full Text] [Related]
15. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
[TBL] [Abstract][Full Text] [Related]
16. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
Yang M; Gu Y; Tang X; Wang T; Liu J
Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
18. SLN and NLC for topical, dermal, and transdermal drug delivery.
Souto EB; Baldim I; Oliveira WP; Rao R; Yadav N; Gama FM; Mahant S
Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958
[No Abstract] [Full Text] [Related]
19. Advances in lipid-based colloid systems as drug carrier for topic delivery.
Zhai Y; Zhai G
J Control Release; 2014 Nov; 193():90-9. PubMed ID: 24939745
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]